Research programme: melanocortin 4 receptor agonists - ChemBridge Research LaboratoriesAlternative Names: MC4 receptor agonists - CRL
Latest Information Update: 16 Jul 2016
At a glance
- Originator ChemBridge Research Laboratories
- Mechanism of Action Melanocortin type 4 receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Metabolic disorders; Obesity
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Obesity in USA
- 16 Jul 2016 No recent reports of development identified for research development in Metabolic-disorders in USA
- 12 Jul 2007 Early research in Obesity in USA (unspecified route)